Dual Specificity Phosphatase 4 Mediates Cardiomyopathy Caused by Lamin A/C (LMNA) Gene Mutation

被引:47
|
作者
Choi, Jason C. [1 ,2 ]
Wu, Wei [1 ,2 ]
Muchir, Antoine [1 ,2 ]
Iwata, Shinichi [1 ]
Homma, Shunichi [1 ]
Worman, Howard J. [1 ,2 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA
基金
美国国家卫生研究院;
关键词
PROTEIN-KINASE PHOSPHATASE-1; HEART-FAILURE; DILATED CARDIOMYOPATHY; MUSCULAR-DYSTROPHY; NUCLEAR-ENVELOPE; INSULIN-RESISTANCE; PREMATURE DEATH; HYPERTROPHY; STRESS; METABOLISM;
D O I
10.1074/jbc.M112.404541
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the lamin A/C gene (LMNA) cause a diverse spectrum of diseases, the most common of which is dilated cardiomyopathy often with skeletal muscular dystrophy. Lamin A and C are fundamental components of the nuclear lamina, a dynamic meshwork of intermediate filaments lining the nuclear envelope inner membrane. Prevailing evidence suggests that the nuclear envelope functions as a signaling node and that abnormality in the nuclear lamina leads to dysregulated signaling pathways that underlie disease pathogenesis. We previously showed that activated ERK1/2 in hearts of a mouse model of LMNA cardiomyopathy (Lmna(H222P/H222P) mice) contributes to disease, but the complete molecular pathogenesis remains poorly understood. Here we uncover a pathogenic role of dual specificity phosphatase 4 (Dusp4), which is transcriptionally induced by ERK1/2. Dusp4 is highly expressed in the hearts of LmnaH222P/H222P mice, and transgenic mice with cardiac-selective overexpression of Dusp4 display heart dysfunction similar to LMNA cardiomyopathy. In both primary tissue and cell culture models, overexpression of Dusp4 positively regulates AKT-mTOR signaling, resulting in impaired autophagy. These findings identify a pathogenic role of Dusp4 in LMNA cardiomyopathy.
引用
收藏
页码:40513 / 40524
页数:12
相关论文
共 50 条
  • [1] Elevated dual specificity protein phosphatase 4 in cardiomyopathy caused by lamin A/C gene mutation is primarily ERK1/2-dependent and its depletion improves cardiac function and survival
    Choi, Jason C.
    Wu, Wei
    Phillips, Elizabeth
    Plevin, Robin
    Sera, Fusako
    Homma, Shunichi
    Worman, Howard J.
    HUMAN MOLECULAR GENETICS, 2018, 27 (13) : 2290 - 2305
  • [2] Dilatation of the Chambers of the Heart Caused by Mutation in Lamin Gene (LMNA)
    Vaikhanskaya, T. G.
    Sivitskaya, L. N.
    Danilenko, N. G.
    Sidorenko, I. V.
    Kurushka, T. V.
    Davydenko, O. G.
    KARDIOLOGIYA, 2016, 56 (05) : 85 - 96
  • [3] Rescue of biosynthesis of nicotinamide adenine dinucleotide protects the heart in cardiomyopathy caused by lamin A/C gene mutation
    Vignier, Nicolas
    Chatzifrangkeskou, Maria
    Rodriguez, Blanca Morales
    Mericskay, Mathias
    Mougenot, Nathalie
    Wahbi, Karim
    Bonne, Gisele
    Muchir, Antoine
    HUMAN MOLECULAR GENETICS, 2018, 27 (22) : 3870 - 3880
  • [4] Temsirolimus Activates Autophagy and Ameliorates Cardiomyopathy Caused by Lamin A/C Gene Mutation
    Choi, Jason C.
    Muchir, Antoine
    Wu, Wei
    Iwata, Shinichi
    Homma, Shunichi
    Morrow, John P.
    Worman, Howard J.
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (144)
  • [5] Phenotype and Prognosis of the Lamin A/C Gene (LMNA) Mutation Carriers in Japan
    Fujino, Noboru
    Hayashi, Kenshi
    Sakata, Kenji
    Nomura, Akihiro
    Kawashiri, Masa-aki
    CIRCULATION JOURNAL, 2018, 82 (11) : 2699 - 2700
  • [6] Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene
    Muchir, Antoine
    Reilly, Sarah A.
    Wu, Wei
    Iwata, Shinichi
    Homma, Shunichi
    Bonne, Gisele
    Worman, Howard J.
    CARDIOVASCULAR RESEARCH, 2012, 93 (02) : 311 - 319
  • [7] Cell signaling abnormalities in cardiomyopathy caused by lamin A/C gene mutations
    Worman, Howard J.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2018, 46 : 37 - 42
  • [8] Modulation of cytoskeleton in cardiomyopathy caused by mutations in LMNA gene
    Chatzifrangkeskou, Maria
    Le Dour, Caroline
    Muchir, Antoine
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2023, 324 (06): : C1223 - C1235
  • [9] Macrocyclic MEK1/2 inhibitor with efficacy in a mouse model of cardiomyopathy caused by lamin A/C gene mutation
    Wu, Wei
    Chordia, Mahendra D.
    Hart, Barry P.
    Kumarasinghe, E. Sathyajith
    Ji, Min K.
    Bhargava, Ajay
    Lawlor, Michael W.
    Shin, Ji-Yeon
    Sera, Fusako
    Homma, Shunichi
    Muchir, Antoine
    Khire, Uday R.
    Worman, Howard J.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (03) : 1004 - 1013
  • [10] Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene
    Wu, Wei
    Shan, Jian
    Bonne, Gisele
    Worman, Howard J.
    Muchir, Antoine
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (7-8): : 632 - 638